SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect pathogens in whole blood. Our mission is to improve healthcare by empowering our customers to effectively treat patients faster than has ever been achieved before. A patent-pending platform technology – a combination of smart microfluidic engineering, centrifugal forces, and sensor fabrication.
commercializing, sepsis, diagnostic device, pathogens
Between €1 million-€ 2.5 million

Articles about SepTec:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as SepTec? We’re happy to assist you with our Startup Sourcing service.